ImmunoViroTherapy Lab

RSS feed of this list

  1. 2012
  2. Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer

    Kangasniemi, L., Parviainen, S., Pisto, T., Koskinen, M., Jokinen, M., Kiviluoto, T. A., Cerullo, V., Jalonen, H., Koski, A. K. E., Kangasniemi, A., Kanerva, A., Pesonen, S. & Hemminki, A. E., 2012, In : International Journal of Cancer. 131, 1, p. 253-263 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

    Diaconu, I., Cerullo, V., Hirvinen, M. L. M., Escutenaire, S., Ugolini, M., Pesonen, S. K., Bramante, S., Parviainen, S., Kanerva, A-M., Loskog, A. S. I., Eliopoulos, A. G., Pesonen, S. & Hemminki, A., 2012, In : Cancer Research. 72, 9, p. 2327-2338 12 p.

    Research output: Contribution to journalArticleScientificpeer-review

  4. Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.

    Pesonen, S., Diaconu, I., Cerullo, V., Escutenaire, S., Raki, M., Kangasniemi, L., Nokisalmi, P., Dotti, G., Guse, K., Laasonen, L., Partanen, K., Karli, E., Haavisto, E., Oksanen, M. K., Karioja-Kallio, A., Hannuksela, P., Sirkka-Liisa, H., Kauppinen, S., Joensuu, T. K., Kanerva, A. & 1 othersHemminki, A. E., 2012, In : International Journal of Cancer. 130, 8, p. 1937-1947 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  5. Oncolytic Adenoviruses for Cancer immunotherapy: Data from Mice, Hamsters, and Humans

    Cerullo, V., Koski, A., Vähä-Koskela, M. & Hemminki, A., 2012, APPLICATIONS OF VIRUSES FOR CANCER THERAPY. Curiel, DT. & Fisher, PB. (eds.). Elsevier Academic Press, Vol. 115. p. 265-318 54 p. (Advances in Cancer Research).

    Research output: Chapter in Book/Report/Conference proceedingChapterScientificpeer-review

  6. Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

    Pesonen, S., Diaconu, I., Kangasniemi, L., Ranki, T., Kanerva, A-M., Pesonen, S. K., Gerdemann, U., Leen, A. M., Kairemo, K., Oksanen, M., Haavisto, E., Sirkka-Liisa, H., Karioja-Kallio, A., Kauppinen, S., Partanen, K. P. L., Laasonen, L., Joensuu, T., Alanko, T., Cerullo, V. & Hemminki, A., 2012, In : Cancer Research. 72, 7, p. 1621-1631 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  7. Oncolytic Viruses for Induction, of Anti-Tumor Immunity

    Tong, A. W., Senzer, N., Cerullo, V., Templeton, N. S., Hemminki, A. E. & Nemunaitis, J., 2012, In : Current Pharmaceutical Biotechnology. 13, 9, p. 1750-1760 11 p.

    Research output: Contribution to journalReview ArticleScientificpeer-review

  8. Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system

    D'Errico, S., Oliviero, G., Amato, J., Borbone, N., Cerullo, V., Hemminki, A., Piccialli, V., Zaccaria, S., Mayol, L. & Piccialli, G., 2012, In : Chemical Communications. 48, 74, p. 9310-9312 3 p.

    Research output: Contribution to journalArticleScientificpeer-review

  9. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4

    Afonso De Carvalho Dias, J. D., Hemminki, O., Diaconu, I., Hirvinen, M., Bonetti, A., Guse, K., Escutenaire, S., Kanerva, A-M., Pesonen, S., Löskog, A., Cerullo, V. & Hemminki, A. E., 2012, In : Gene Therapy (Basingstoke). 19, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  10. Oncolytic adenoviruses A potent form of tumor immunovirotherapy

    Cerullo, V., Vähä-Koskela, M. & Hemminki, A., Sep 2012, In : OncoImmunology. 1, 6, p. 979-981 3 p.

    Research output: Contribution to journalArticleScientificpeer-review

  11. Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

    Hemminki, O., Diaconu, I., Cerullo, V., Pesonen, S. K., Kanerva, A-M., Joensuu, T., Kairemo, K., Laasonen, L., Partanen, K., Kangasniemi, L., Lieber, A., Pesonen, S. & Hemminki, A., 1 Sep 2012, In : Molecular therapy. 20, 9, p. 1821-1830 10 p.

    Research output: Contribution to journalArticleScientificpeer-review

Previous 1 2 3 4 5 6 7 Next